Nader Francois

Director at MRNA; President, CEO and Director at NPS PHARMACEUTICALS INC

Sold, on record
$11.9M
Dollars the filings state
Form 4 sales
4
Latest May 10, 2022
Form 144 notices
0
Proposed sales
Companies
2
Filed as an executive or holder

Companies

Sales by reason

0
Routine
0
Plan not stated
0
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Sales by company

Shares sold, every Form 4 sale on record.

Timeline

  1. 1 Form 4 sale NPS PHARMACEUTICALS INCPlan not stated
    Feb 3, 2010 2010

    Sold 19,350 shares at $3.37 ($65k)

    Nader Francois, President, CEO and Director

    Sold 11.4% of holdings ($570k position)149,658 shares leftFirst sale on recordFiling

  2. 2 Form 4 sale NPS PHARMACEUTICALS INCUnusual
    Apr 10, 2013 +1162 days

    Sold 448,367 shares at $11.32 ($5.1M)

    Nader Francois, President, CEO and Director

    Sold 67.3% of holdings ($7.5M position)217,478 shares leftFirst sale on recordFiling

  3. 3 Form 4 sale NPS PHARMACEUTICALS INCUnusual
    Sep 27, 2013 +170 days

    Sold 193,458 shares at $32.93 ($6.4M)

    Nader Francois, President, CEO and Director

    Sold 68.8% of holdings ($9.3M position)87,820 shares leftFiling

  4. 4 Form 4 sale MRNAPlan not stated
    May 10, 2022 +3147 days

    Sold 3,196 shares at $136.10 ($435k)

    Nader Francois, Director

    Sold 13.4% of holdings ($3.2M position)20,607 shares leftFirst sale on recordFiling

Every transaction

Loading transactions…

Sales and notices (4)

Form 144 notices and Form 4 sales by Nader Francois
Source
May 10, 2022May 12, 2022MRNADirectorForm 4 sale3,196$435k13.4%Plan not statedSEC
Sep 27, 2013Sep 30, 2013NPS PHARMACEUTICALS INCPresident, CEO and DirectorForm 4 sale193,458$6.4M68.8%UnusualSEC
Apr 10, 2013Apr 10, 2013NPS PHARMACEUTICALS INCPresident, CEO and DirectorForm 4 sale448,367$5.1M67.3%UnusualSEC
Feb 3, 2010Apr 2, 2010NPS PHARMACEUTICALS INCPresident, CEO and DirectorForm 4 sale19,350$65k11.4%Plan not statedSEC